Request Demo
Last update 05 Dec 2025
MB-CART 2219.1
Last update 05 Dec 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms MB-CART 2219.1 |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD22 inhibitors(CD22 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with MB-CART 2219.1NCT07108868
A Phase I Dose Finding Study of MB-CART2219.1 Targeting CD19/CD22 in Adult and Pediatric Patients With Relapsed/Refractory B-cell Malignancies
100 Clinical Results associated with MB-CART 2219.1
Login to view more data
100 Translational Medicine associated with MB-CART 2219.1
Login to view more data
100 Patents (Medical) associated with MB-CART 2219.1
Login to view more data
100 Deals associated with MB-CART 2219.1
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Burkitt Lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Chronic Lymphocytic Leukemia | Phase 1 | Germany | 23 Jun 2025 | |
| Follicular Lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Large B-cell lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Mantle-Cell Lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Marginal Zone B-Cell Lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | Germany | 23 Jun 2025 | |
| Acute Lymphoblastic Leukemia | Preclinical | Germany | 12 Aug 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free